Literature DB >> 20065129

Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis.

Annette Langer-Gould1, Rohit Gupta, Stella Huang, Adam Hagan, Kondala Atkuri, Amethyst D Leimpeter, Kathleen B Albers, Eleni Greenwood, Stephen K Van Den Eeden, Lawrence Steinman, Lorene M Nelson.   

Abstract

OBJECTIVE: To determine whether fluctuations in functional T-cell subsets can explain why multiple sclerosis (MS) relapses decline during pregnancy and increase in the postpartum period.
DESIGN: Case-control study.
SETTING: Kaiser Permanente Northern California and Stanford University. PARTICIPANTS: Twenty-six pregnant women with MS and 24 age-matched, pregnant controls. Intervention We prospectively followed up the pregnant women with MS and the age-matched, pregnant controls; conducted structured interviews; and collected peripheral blood mononuclear cells during each trimester and 2, 4, 6, 9, and 12 months post partum. MAIN OUTCOME MEASURES: Sixteen functional cell types, including interferon-gamma (IFN-gamma)- and tumor necrosis factor-producing T-cell subsets, were measured using multicolor flow cytometry. Since these cell types may also fluctuate with pregnancy, lactational amenorrhea, or MS treatment, the data were analyzed taking into account these factors.
RESULTS: Fifteen women with MS (58%) had relapses during the postpartum year. CD4(+)IFN-gamma-producing cells fluctuated with MS relapses, declining during pregnancy in women with MS (P < .001) and continuing to decline after parturition in women with relapses (P = .001), yet rising or remaining stable in women with nonrelapsing MS or healthy pregnant women. Lactational amenorrhea was associated with a rise in CD4(+)IFN-gamma-producing cells in women with MS (P = .009). In contrast, CD4(+) tumor necrosis factor-producing cells decreased during lactational amenorrhea in all groups of women and, once this was taken into account, obscured any relationship to MS relapses. CD8(+)IFN-gamma-producing cells were elevated in women with MS throughout the study (P < .001) but did not fluctuate with relapses.
CONCLUSIONS: Our findings suggest that a decline in circulating CD4(+)IFN-gamma-producing cells leads to postpartum MS relapses. Our findings also suggest that the decline in these cells may begin during late pregnancy and that lactational amenorrhea induced by exclusive breastfeeding may be able to interrupt this process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065129     DOI: 10.1001/archneurol.2009.304

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  19 in total

1.  Breastfeeding, ovulatory years, and risk of multiple sclerosis.

Authors:  Annette Langer-Gould; Jessica B Smith; Kerstin Hellwig; Edlin Gonzales; Samantha Haraszti; Corinna Koebnick; Anny Xiang
Journal:  Neurology       Date:  2017-07-12       Impact factor: 9.910

2.  Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity.

Authors:  Anna Ghirardello; Salvatore Gizzo; Marco Noventa; Michela Quaranta; Amerigo Vitagliano; Nicoletta Gallo; Giorgia Pantano; Marianna Beggio; Chiara Cosma; Michele Gangemi; Mario Plebani; Andrea Doria
Journal:  J Assist Reprod Genet       Date:  2015-10-14       Impact factor: 3.412

Review 3.  Prolactin, autoimmunity, and motherhood: when should women avoid breastfeeding?

Authors:  Vânia Vieira Borba; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2019-01-11       Impact factor: 2.980

Review 4.  Sex-related factors in multiple sclerosis susceptibility and progression.

Authors:  Rhonda R Voskuhl; Stefan M Gold
Journal:  Nat Rev Neurol       Date:  2012-03-27       Impact factor: 42.937

Review 5.  Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.

Authors:  Maria Pia Amato; Emilio Portaccio
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

Review 6.  Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Semin Immunopathol       Date:  2016-08-08       Impact factor: 9.623

7.  Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy.

Authors:  Nadja Borisow; Andrea Döring; Caspar F Pfueller; Friedemann Paul; Jan Dörr; Kerstin Hellwig
Journal:  EPMA J       Date:  2012-06-22       Impact factor: 6.543

8.  Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.

Authors:  Luisa Pastò; Emilio Portaccio; Angelo Ghezzi; Bahia Hakiki; Marta Giannini; Lorenzo Razzolini; Elisa Piscolla; Laura De Giglio; Carlo Pozzilli; Damiano Paolicelli; Maria Trojano; Maria Giovanna Marrosu; Francesco Patti; Loredana La Mantia; Gian Luigi Mancardi; Claudio Solaro; Rocco Totaro; Maria Rosaria Tola; Valeria Di Tommaso; Alessandra Lugaresi; Lucia Moiola; Vittorio Martinelli; Giancarlo Comi; Maria Pia Amato
Journal:  BMC Neurol       Date:  2012-12-31       Impact factor: 2.474

9.  Shen-Qi-Jie-Yu-Fang has antidepressant effects in a rodent model of postpartum depression by regulating the immune organs and subsets of T lymphocytes.

Authors:  Miao Qu; Qisheng Tang; Xiaoli Li; Ruizhen Zhao; Jingya Li; Hong Xu; Yushan Gao; Yingqiu Mao
Journal:  Neuropsychiatr Dis Treat       Date:  2015-06-25       Impact factor: 2.570

Review 10.  Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies.

Authors:  Isabella Laura Simone; Carla Tortorella; Alma Ghirelli
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.